HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment.

Abstract
Blepharospasm is seen in many cases of Parkinsonism including progressive supranuclear palsy. These patients usually respond well to botulinum toxin, however some patients subsequently fail to respond to even higher doses of botulinum toxin after an initial good response. They should not be considered failure of treatment with botulinum toxin, as a significant number of these patients have underlying apraxia of eyelid opening in addition to blepharospasm, which may be the cause of failure to respond to botulinum toxin. Combination of eyelid crutches or myomectomy with botulinum toxin is more effective in these patients as compared to an individual treatment modality. In this report, we present two patients with progressive supranuclear palsy who failed to respond to botulinum toxin because they had underlying apraxia of lid opening. Partial myomectomy in one patient and eyelid crutches in the other in combination with botulinum toxin lead to a much better response to botulinum toxin.
AuthorsAbdul Qayyum Rana, Reema Shah
JournalActa neurologica Belgica (Acta Neurol Belg) Vol. 112 Issue 1 Pg. 95-6 (Mar 2012) ISSN: 2240-2993 [Electronic] Italy
PMID22427299 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Neurotoxins
  • Botulinum Toxins, Type A
Topics
  • Aged
  • Apraxias (complications, drug therapy)
  • Blepharospasm (complications, drug therapy)
  • Botulinum Toxins, Type A (therapeutic use)
  • Eyelids (drug effects, physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Neurotoxins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: